Current controversies around tight glucose control in critically ill patients

Purpose of reviewThis review updates our knowledge on the benefits and risks of tight glucose control by intensive insulin therapy in critically ill patients, as well as discussing unanswered questions related to the subject. Recent findingsAt the cellular level, the toxic effects of elevated and highly variable glucose concentration are related to an increase in oxidative stress and to several toxic intracellular derivates generated as by-products of the glycolytic pathway. Clinically, several recent studies have suggested that the optimal target for blood glucose may be higher than the ‘normal’ values of 4.4–6.1 mmol/l for various categories of patients. Also, the variability in glucose level appears to be an important determinant of glucose toxicity. Conflicting data on the hazards of hypoglycaemia are emerging. SummaryPractical recommendations for the implementation of tight glucose control using intensive insulin therapy cannot be disseminated until questions relating to optimal blood glucose level and the corresponding categories of patients have been resolved. The issues of glucose variability and the most efficient method of preventing hypoglycaemia will probably represent important parameters for comparing the safety and quality of protocols used for tight glucose control.

[1]  G. Van den Berghe,et al.  Tight control of glycaemia in critically ill patients , 2002, Current opinion in clinical nutrition and metabolic care.

[2]  James Stephen Krinsley,et al.  Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. , 2004, Mayo Clinic proceedings.

[3]  Anthony N Thomas,et al.  Evaluation of short-term consequences of hypoglycemia in an intensive care unit. , 2007, Critical care medicine.

[4]  D. Cook,et al.  Glycemic control in the ICU: a multicenter survey , 2004, Intensive Care Medicine.

[5]  C. Szabó,et al.  Poly(ADP-Ribose) Polymerase Inhibitors Ameliorate Nephropathy of Type 2 Diabetic Leprdb/db Mice , 2006, Diabetes.

[6]  P. Cryer.  Mechanisms of sympathoadrenal failure and hypoglycemia in diabetes. , 2006, The Journal of clinical investigation.

[7]  T. Evans,et al.  Glucose control and mortality in critically ill patients. , 2004, JAMA.

[8]  A. Ceriello.  Oxidative stress and diabetes-associated complications. , 2006, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[9]  J. Ligtenberg,et al.  Hyperglycaemia in critically ill patients: marker or mediator of mortality? , 2006, Critical care.

[10]  P. Coriat,et al.  Poor Intraoperative Blood Glucose Control Is Associated with a Worsened Hospital Outcome after Cardiac Surgery in Diabetic Patients , 2005, Anesthesiology.

[11]  B. Bistrian,et al.  Intensive insulin therapy in critically ill patients. , 2002, The New England journal of medicine.

[12]  J. Preiser,et al.  Is it time for implementation of tight glycaemia control by intensive insulin therapy in every ICU? , 2006, Critical care.

[13]  Atul Malhotra,et al.  Intensive insulin in intensive care. , 2006, The New England journal of medicine.

[14]  Miet Schetz,et al.  Intensive Insulin Therapy in Mixed Medical/Surgical Intensive Care Units , 2006, Diabetes.

[15]  Rinaldo Bellomo,et al.  Variability of Blood Glucose Concentration and Short-term Mortality in Critically Ill Patients , 2006, Anesthesiology.

[16]  M. Mcmahon,et al.  Glycemic control and nutrition in the intensive care unit , 2006, Current opinion in clinical nutrition and metabolic care.

[17]  J. Preiser,et al.  Tight blood glucose control: a recommendation applicable to any critically ill patient? , 2004, Critical care.

[18]  Edward Abraham,et al.  Intensive insulin therapy in critical illness. , 2005, American journal of respiratory and critical care medicine.

[19]  Marcus J Schultz,et al.  Predisposing factors for hypoglycemia in the intensive care unit* , 2006, Critical care medicine.

[20]  I. Hirsch,et al.  Should minimal blood glucose variability become the gold standard of glycemic control? , 2005, Journal of diabetes and its complications.

[21]  A. Brett.  Intensive Insulin Therapy in the Medical ICU , 2006 .

[22]  M. Brownlee.  Biochemistry and molecular cell biology of diabetic complications , 2001, Nature.

[23]  Jean-Paul Cristol,et al.  Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. , 2006, JAMA.

[24]  Jaap E Tulleken,et al.  Towards a feasible algorithm for tight glycaemic control in critically ill patients: a systematic review of the literature , 2006, Critical care.

[25]  M Schetz,et al.  Intensive insulin therapy in critically ill patients. , 2001, The New England journal of medicine.

[26]  Margaret M Parker,et al.  Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock , 2004, Critical care medicine.

[27]  Timothy W. Evans,et al.  Glucose Control and Mortality in Critically Ill Patients , 2003 .

[28]  G. Van den Berghe,et al.  Glucose, insulin and myocardial ischaemia , 2006, Current opinion in clinical nutrition and metabolic care.

[29]  K. Murthy,et al.  Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation , 2001, Nature Medicine.

[30]  V. Gabbanelli,et al.  Correlation between hyperglycemia and mortality in a medical and surgical intensive care unit. , 2005, Minerva anestesiologica.